Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Apr;43(4):554–557. doi: 10.1038/bjc.1981.81

Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.

S Ben-Efraim, R Ophir, E H Relyveld
PMCID: PMC2010632  PMID: 6786316

Full text

PDF
554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bubbers J. E., Henney C. S. Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells. J Immunol. 1975 Mar;114(3):1126–1131. [PubMed] [Google Scholar]
  2. Csaba G. Attempts to induce antitumour immunity with living attenuated cells. Neoplasma. 1967;14(2):167–175. [PubMed] [Google Scholar]
  3. Dennert G., Tucker D. F. Selective priming of T cells by chemically altered cell antigens. J Exp Med. 1972 Sep 1;136(3):656–661. doi: 10.1084/jem.136.3.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diamantstein T., Ulmer A. The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology. 1975 Jan;28(1):113–119. [PMC free article] [PubMed] [Google Scholar]
  5. Eisen H. N., Simms E. S., Potter M. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry. 1968 Nov;7(11):4126–4134. doi: 10.1021/bi00851a048. [DOI] [PubMed] [Google Scholar]
  6. Frost P., Edwards A., Sanderson C. Discussion paper: the use of glutaraldehyde fixation for the study of the immune response to syngeneic tumor antigen. Ann N Y Acad Sci. 1976;276:91–96. doi: 10.1111/j.1749-6632.1976.tb41638.x. [DOI] [PubMed] [Google Scholar]
  7. Frost P., Sanderson C. J. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells. Cancer Res. 1975 Oct;35(10):2646–2650. [PubMed] [Google Scholar]
  8. Kataoka T., Kobayashi H., Sakurai Y. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents. Cancer Res. 1978 May;38(5):1202–1207. [PubMed] [Google Scholar]
  9. Kataoka T., Oh-hashi F., Sakurai Y. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity. Gan. 1979 Apr;70(2):155–164. [PubMed] [Google Scholar]
  10. Kataoka T., Oh-hashi F., Tsukagoshi S., Sakurai Y. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. Cancer Res. 1977 Dec;37(12):4416–4419. [PubMed] [Google Scholar]
  11. Kataoka T., Oh-hashi F., Tsukagoshi S., Sakurai Y. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A. Cancer Res. 1977 Apr;37(4):964–968. [PubMed] [Google Scholar]
  12. Kataoka T., Tsukagoshi S., Sakurai Y., Okabe M. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole. Gan. 1979 Aug;70(4):515–519. [PubMed] [Google Scholar]
  13. Kluchareva T. E., Matveeva V. A., Deichman G. I. Sensitivity of TSTA and species-specific cell membrane antigens of tumor cells to glutaraldehyde treatment. Neoplasma. 1978;25(3):273–278. [PubMed] [Google Scholar]
  14. Mitchison N. A. Immunologic approach to cancer. Transplant Proc. 1970 Mar;2(1):92–103. [PubMed] [Google Scholar]
  15. Parish C. R. Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol. 1972 Apr;2(2):143–151. doi: 10.1002/eji.1830020210. [DOI] [PubMed] [Google Scholar]
  16. Powell P. C. Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines. Nature. 1975 Oct 23;257(5528):684–685. doi: 10.1038/257684a0. [DOI] [PubMed] [Google Scholar]
  17. Price M. R., Dennick R. G., Robins R. A., Baldwin R. W. Modification of the immunogenicity and antigenicity of rat hepatoma cells. I. Cell-surface stabilization with glutaraldehyde. Br J Cancer. 1979 Jun;39(6):621–629. doi: 10.1038/bjc.1979.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sanderson C. J., Frost P. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells. Nature. 1974 Apr 19;248(5450):690–691. doi: 10.1038/248690a0. [DOI] [PubMed] [Google Scholar]
  19. Tomecki J. The influence of immunization of Syrian hamsters with tumor cells treated with glutaraldehyde on transplantation immunity and the cytotoxic effect of lymphocytes on polyoma tumor cells. Arch Immunol Ther Exp (Warsz) 1979;27(1-2):209–217. [PubMed] [Google Scholar]
  20. Williams W. H., Krueger R. G. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice. J Natl Cancer Inst. 1972 Dec;49(6):1613–1620. doi: 10.1093/jnci/49.6.1613. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES